+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-08-19Number of Pages: 185

Veterinary Vaccines Market (Animal Type - Companion Animals (Equine, Canine, and Feline) and Livestock Animals (Bovine, Ovine, Porcine, and Poultry); Technology Type - Inactivated Vaccines, Live Attenuated Vaccines, Conjugate Vaccines, and Toxoid Vaccines) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Chapter 1 Preface
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Key Questions Answered

Chapter 2 Assumptions and Research Methodology
2.1 Report Assumptions
2.2 Acronyms Used
2.3 Research Methodology

Chapter 3 Executive Summary 
3.1 Global Veterinary Vaccines Market Snapshot
3.2 Market Opportunity Map

Chapter 4 Market Overview
4.1 Product Overview
4.2 Key Industry Events
4.3 Disease Outbreak Globally: Livestock Animals Disease
4.4 Main (Vector Borne Disease) VBDs affecting livestock
4.5 List of countries representing each virus pool (FMD) for the period 2010–2014 
4.6 Animal Population (Mn), by Country in 2015
4.7 Regulatory Scenario

Chapter 5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 White Space Analysis

Chapter 6 Veterinary Vaccines Market Analysis, by Technology Type, (US$ Mn) 2014–2024
6.1 Key Findings
6.2 Introduction
6.3 Inactivated Vaccines
6.4 Live Attenuated Vaccines
6.5 Conjugate Vaccines
6.6 Toxoid Vaccines
6.7 Recombinant Vaccines
6.8 DNA Vaccines
6.9 Key Trends
6.10 Veterinary Vaccines Market Attractiveness Analysis, by Technology Type, 2015

Chapter 7 Veterinary Vaccines Market Analysis, by Animal Type, (US$ Mn), 2014–2024
7.1 Key Findings
7.2 Introduction
7.3 Veterinary vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2014–2024
     7.3.1 Equine
     7.3.2 Canine
     7.3.3 Feline
7.4 Veterinary vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2014–2024
     7.4.1 Bovine
     7.4.2 Ovine
     7.4.3 Porcine
     7.4.4 Poultry
7.5 Key Trends
7.6 Veterinary Vaccines Market Attractiveness Analysis, by Animal Type

Chapter 8 Veterinary Vaccines Market Analysis, by Region, (US$ Mn), 2014–2024
8.1 North America
8.2 Europe
8.3 Asia Pacific
8.4 Latin America
8.5 Middle East & Africa
8.6 Geographical Scenario
8.7 Veterinary Vaccines Market Attractiveness Analysis, by Region, 2015

Chapter 9 North America Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024
9.1 North America Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014–2024
     9.1.1 Inactivated Vaccines
     9.1.2 Conjugate Vaccines
     9.1.3 Live Attenuated Vaccines
     9.1.4 Toxoid Vaccines
     9.1.5 Other Vaccines
9.2 North America Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014–2024
     9.2.1 Animal Type
             9.2.1.1 Companion Animals
                       9.2.1.1.1 Equine 
                       9.2.1.1.2 Canine 
                       9.2.1.1.3 Feline 
             9.2.1.2 Livestock Animals
                       9.2.1.2.1 Bovine
                       9.2.1.2.2 Ovine 
                       9.2.1.2.3 Porcine 
                       9.2.1.2.4 Poultry 
                       9.2.1.2.5 Others 
9.3 U.S. Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024
9.4 Canada Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024

Chapter 10 Europe Veterinary vaccines Market Revenue Analysis, (US$ Mn), 2014–2024
10.1 Europe Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014–2024
     10.1.1 Inactivated Vaccines
     10.1.2 Conjugate Vaccines
     10.1.3 Live Attenuated Vaccines
     10.1.4 Toxoid Vaccines
     10.1.5 Other Vaccines
10.2 Europe Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014–2024
     10.2.1 Animal Type
             10.2.1.1 Companion Animals
                       10.2.1.1.1 Equine 
                       10.2.1.1.2 Canine 
                       10.2.1.1.3 Feline 
             10.2.1.2 Livestock Animals
                       10.2.1.2.1 Bovine
                       10.2.1.2.2 Ovine 
                       10.2.1.2.3 Porcine 
                       10.2.1.2.4 Poultry 
                       10.2.1.2.5 Others 
10.3 Europe Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2014–2024
10.4 Germany Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024
10.5 U.K. Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024

Chapter 11 Asia Pacific Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024
11.1 Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014–2024
     11.1.1 Inactivated Vaccines
     11.1.2 Conjugate Vaccines
     11.1.3 Live Attenuated Vaccines
     11.1.4 Toxoid Vaccines
     11.1.5 Other Vaccines
11.2 Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014–2024
     11.2.1 Animal Type
             11.2.1.1 Companion Animals
                       11.2.1.1.1 Equine 
                       11.2.1.1.2 Canine 
                       11.2.1.1.3 Feline 
             11.2.1.2 Livestock Animals
                       11.2.1.2.1 Bovine
                       11.2.1.2.2 Ovine 
                       11.2.1.2.3 Porcine 
                       11.2.1.2.4 Poultry 
                       11.2.1.2.5 Others 
11.3 Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2014–2024
11.4 China Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024
11.5 Japan Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024

Chapter 12 Latin America Veterinary vaccines Market Revenue Analysis, (US$ Mn), 2014–2024
12.1 Latin America Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014–2024
     12.1.1 Inactivated Vaccines
     12.1.2 Conjugate Vaccines
     12.1.3 Live Attenuated Vaccines     
     12.1.4 Toxoid Vaccines
     12.1.5 Other Vaccines
12.2 Latin America Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014–2024
     12.2.1 Animal Type
             12.2.1.1 Companion Animals
                       12.2.1.1.1 Equine 
                       12.2.1.1.2 Canine 
                       12.2.1.1.3 Feline 
             12.2.1.2 Livestock Animals
                       12.2.1.2.1 Bovine
                       12.2.1.2.2 Ovine 
                       12.2.1.2.3 Porcine 
                       12.2.1.2.4 Poultry 
                       12.2.1.2.5 Others 
12.3 Latin America Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2014–2024
12.4 Brazil Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024
12.5 Mexico Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024

Chapter 13 Middle East & Africa Veterinary Vaccines Market Revenue Analysis, (US$ Mn), 2014–2024
13.1 Middle East & Africa Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014–2024
     13.1.1 Inactivated Vaccines
     13.1.2 Conjugate Vaccines
     13.1.3 Live Attenuated Vaccines
     13.1.4 Toxoid Vaccines
     13.1.5 Other Vaccines
13.2 Middle East & Africa Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014–2024
     13.2.1 Animal Type
             13.2.1.1 Companion Animals
                       13.2.1.1.1 Equine 
                       13.2.1.1.2 Canine 
                       13.2.1.1.3 Feline 
             13.2.1.2 Livestock Animals
                       13.2.1.2.1 Bovine
                       13.2.1.2.2 Ovine 
                       13.2.1.2.3 Porcine 
                       13.2.1.2.4 Poultry 
                       13.2.1.2.5 Others 
13.3 Middle East & Africa Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2014–2024
13.4 Saudi Arabia Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024

Chapter 14 Competitive Landscape
14.1 Veterinary Vaccine Market Share Analysis, by Company, (2015)
14.2 Competition Matrix
     14.2.1 Bayer AG 
     14.2.2 Bimeda, Inc. 
     14.2.3 Boehringer Ingelheim GmbH 
     14.2.4 Ceva Santé Animale 
     14.2.5 Eli Lilly and Company (Elanco Animal Health) 
     14.2.6 Merck Animal Health 
     14.2.7 Sanofi S.A. (Merial Animal Health) 
     14.2.8 Virbac 
     14.2.9 Zoetis, Inc.
14.3 Company Profiles
     14.3.1 Bayer AG
             14.3.1.1 Company Details
             14.3.1.2 Company Description
             14.3.1.3 Business Overview
             14.3.1.4 SWOT Analysis
             14.3.1.5 Financials
             14.3.1.6 Strategic Overview
             14.3.1.7 Product Portfolio
             14.3.1.8 Recent Developments 
     14.3.2 Bimeda, Inc. 
             14.3.2.1 Company Details
             14.3.2.2 Company Description
             14.3.2.3 Business Overview
             14.3.2.4 SWOT Analysis
             14.3.2.5 Financials
             14.3.2.6 Strategic Overview
             14.3.2.7 Product Portfolio
             14.3.2.8 Recent Developments 
     14.3.3 Boehringer Ingelheim GmbH 
             14.3.3.1 Company Details
             14.3.3.2 Company Description
             14.3.3.3 Business Overview
             14.3.3.4 SWOT Analysis
             14.3.3.5 Financials
             14.3.3.6 Strategic Overview
             14.3.3.7 Product Portfolio
             14.3.3.8 Recent Developments 
     14.3.4 Ceva Santé Animale 
             14.3.4.1 Company Details
             14.3.4.2 Company Description
             14.3.4.3 Business Overview
             14.3.4.4 SWOT Analysis
             14.3.4.5 Financials
             14.3.4.6 Strategic Overview
             14.3.4.7 Product Portfolio
             14.3.4.8 Recent Developments 
     14.3.5 Eli Lilly and Company (Elanco Animal Health) 
             14.3.5.1 Company Details
             14.3.5.2 Company Description
             14.3.5.3 Business Overview
             14.3.5.4 SWOT Analysis
             14.3.5.5 Financials
             14.3.5.6 Strategic Overview
             14.3.5.7 Product Portfolio
             14.3.5.8 Recent Developments 
     14.3.6 Merck Animal Health 
             14.3.6.1 Company Details
             14.3.6.2 Company Description
             14.3.6.3 Business Overview
             14.3.6.4 SWOT Analysis
             14.3.6.5 Financials
             14.3.6.6 Strategic Overview
             14.3.6.7 Product Portfolio
             14.3.6.8 Recent Developments 
     14.3.7 Sanofi S.A. (Merial Animal Health) 
             14.3.7.1 Company Details
             14.3.7.2 Company Description
             14.3.7.3 Business Overview
             14.3.7.4 SWOT Analysis
             14.3.7.5 Financials
             14.3.7.6 Strategic Overview
             14.3.7.7 Product Portfolio
             14.3.7.8 Recent Developments 
     14.3.8 Virbac 
             14.3.8.1 Company Details
             14.3.8.2 Company Description
             14.3.8.3 Business Overview
             14.3.8.4 SWOT Analysis
             14.3.8.5 Financials
             14.3.8.6 Strategic Overview
             14.3.8.7 Product Portfolio
             14.3.8.8 Recent Developments 
     14.3.9 Zoetis, Inc.
             14.3.9.1 Company Details
             14.3.9.2 Company Description
             14.3.9.3 Business Overview
             14.3.9.4 SWOT Analysis
             14.3.9.5 Financials
             14.3.9.6 Strategic Overview
             14.3.9.7 Product Portfolio
             14.3.9.8 Recent Developments 

List of Figures

FIG. 1 Global Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2015 and 2024
FIG. 2 Global Inactivated Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 3 Global Live Attenuated Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 4 Global Conjugate Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 5 Global Toxoid Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 6 Global Recombinant Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 7 Global DNA Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 8 Global Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
FIG. 9 Global Equine Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 10 Global Canine Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 11 Global Feline Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 12 Global Companion Animal Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 13 Global Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
FIG. 14 Global Bovine Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 15 Global Ovine Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 16 Global Porcine Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 17 Global Poultry Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 18 Global Veterinary Vaccines Market Value Share Analysis, by Region, 2015 and 2024
FIG. 19 Veterinary Vaccines Market Attractiveness Analysis, by Region, (US$ Mn), 2014–2024
FIG. 20 Veterinary Vaccines Market Attractiveness Analysis, by Technology Type, (US$ Mn), 2014–2024
FIG. 21 Veterinary Vaccines Market Attractiveness Analysis, by Animal Type, (US$ Mn), 2014–2024
FIG. 22 North America Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
FIG. 23 North America Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
FIG. 24 North America Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
FIG. 25 North America Market Value Share Analysis, by Country, (US$ Mn), 2015 and 2024
U.S. Veterinary Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 26 U.S. Veterinary Vaccines Market Revenue, (US$ Mn), 2014–2024 
FIG. 27 Canada Veterinary Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 28 Europe Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2015 and 2024
FIG. 29 Europe Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024 
FIG. 30 Europe Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
FIG. 31 Europe Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2015 and 2024
FIG. 32 Germany Veterinary Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 33 U.K. Veterinary Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 34 Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2015 and 2024
FIG. 35 Asia Pacific Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
FIG. 36 Asia Pacific Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
FIG. 37 Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn) 2015 and 2024
FIG. 38 China Veterinary Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 39 Japan Veterinary Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 40 Latin America Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2015 and 2024
FIG. 41 Latin America Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
FIG. 42 Latin America Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
FIG. 43 Latin America Market Value Share Analysis, by Country, (US$ Mn), 2015 and 2024
FIG. 44 Brazil Veterinary Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 45 Mexico Veterinary Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 46 Middle East & Africa Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2015 and 2024
FIG. 47 Middle East & Africa Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
FIG. 48 Middle East & Africa Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
FIG. 49 Saudi Arabia Veterinary Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 50 Global Veterinary Vaccines Market Share Analysis, by Company (%) (2015)

List of Tables

Table 1. Global Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014–2024
Table 2. Global Veterinary Vaccines (companion animals) Market Size Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 3. Global Veterinary Vaccines (livestock animals) Market Size Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 4. Global Veterinary Vaccines Market Size Forecast, by Region, (US$ Mn), 2014–2024
Table 5. North America Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014–2024
Table 6. Global Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 7. Global Veterinary Vaccines (livestock animals) Market Size Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 8. North America Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014–2024
Table 9. Europe Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014–2024
Table 10. Europe Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 11. Europe Veterinary Vaccines (livestock animals) Market Size (US$ Mn) Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 12. Europe Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014–2024
Table 13. Asia Pacific Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014–2024
Table 14. Asia Pacific Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 15. Asia Pacific Veterinary Vaccines (livestock animals) Market Size Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 16. Asia Pacific Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014–2024
Table 17. Latin America Veterinary Vaccines Market Size (US$ Mn) Forecast, by Technology Type, (US$ Mn), 2014–2024
Table 18. Latin America Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 19. Latin America Veterinary Vaccines (livestock animals) Market Size (US$ Mn) Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 20. Latin America Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014–2024
Table 21. Middle East & Africa Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014–2024 
Table 22. Middle East & Africa Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 23. Middle East & Africa Veterinary Vaccines (livestock animals) Market Size (US$ Mn) Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 24. Middle East & Africa Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014–2024


 
 
Back To Top